MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK.
Department of Clinical Neurosciences, UCL Institute of Neurology, London, UK.
Trends Endocrinol Metab. 2018 Jul;29(7):452-454. doi: 10.1016/j.tem.2018.03.009. Epub 2018 Apr 7.
Groundbreaking work by Kadenbach and colleagues in the 1980s revealed the presence of 13 subunits in the mammalian mitochondrial cytochrome-c oxidase (COX; Complex IV). This observation stood the test of time until 2012 when it was demonstrated that NDUFA4, a polypeptide previously attributed to mitochondrial Complex I, was a 14th subunit of COX. In his recent opinion article, Kadenbach argued that NDUFA4 is not a subunit of COX. However, based on the findings that NDUFA4 deficiency results in a severe loss of COX activity and that NDUFA4 represents a stoichiometric component of the individual COX complex, we reason that NDUFA4 is a bona fide COX subunit and propose renaming it as COX subunit FA4 (COXFA4).
20 世纪 80 年代,Kadenbach 及其同事的开创性工作揭示了哺乳动物线粒体细胞色素 c 氧化酶(COX;复合物 IV)存在 13 个亚基。这一观察结果经受住了时间的考验,直到 2012 年,人们才证明先前被认为是线粒体复合物 I 的多肽 NDUFA4 是 COX 的第 14 个亚基。在他最近的观点文章中,Kadenbach 认为 NDUFA4 不是 COX 的亚基。然而,根据 NDUFA4 缺乏导致 COX 活性严重丧失的发现,以及 NDUFA4 是单个 COX 复合物的化学计量成分这一事实,我们推断 NDUFA4 是真正的 COX 亚基,并提议将其重新命名为 COX 亚基 FA4(COXFA4)。